• About us
    • Profile
    • Contributors
    • Staff
    • Address
    • Contact Us
  • Articles
    • Canada
    • USA
    • International
  • Topics
    • Access to Medicines
    • Innovation
    • Comparative Effectiveness
    • Health Technology Assessment
    • Importation
    • Global Public Health
    • Emerging Markets
    • Patient Safety
    • Patient Advocacy
  • Events
  • Publications
    • Presentations
    • Reports and Research Papers
  • Register
Home  |  Topics  |  Comparative Effectiveness


global health
1. IPP Environmental Scan
2. U.S. Hearings on Global Health
3. Case studies for global health
4. Cancer, cardiovascular and other type 1 diseases will cause over three quarters of all deaths by 2030
5. Issue Update: Amid patient concerns, patent issues take top priority at the World Health Organization
6. First WHO report on NTDs highlights ongoing commitment of innovative drug companies
7. Global report on maternal mortality shows 34% decline since 1990
8. Global distribution of neglected tropical diseases
9. Global partnerships working to eradicate malaria - World Malaria Day 2010
10. Counterfeit medicines threaten public health in Peru
<< Start < Prev 1 2 Next > End >>
Powered by Tags for Joomla
 

Top Topics

  • access to medicines
  • canada
  • chronic disease
  • disease management
  • global health
  • health policy
  • health spending
  • innovation
  • usa
  • world health organization

Latest News

  • Social media is changing how epidemiologists discover and track disease outbreaks
  • CBO report: further restricting DTC advertising may be bad for public health
  • UN hosts interactive hearing on NCDs
  • Social media can greatly enhance the effectiveness of traditional marketing
  • 64th World Health Assembly – resolutions and highlights

Popular Articles

  • Chronic Disease highlighted at World Economic Forum 2011
  • Pharmacy reform in Ontario to address overpriced generic medicines
  • Global partnerships facilitate access to medicines
  • Treatment of rare disorders: U.S and Europe enact legislation to encourage innovation and access while Canada lags behind
  • Accessing Drugs for Rare Diseases in Canada: The Patient Perspective
 

Social Media

Follow whadvocacy on Twitter

linkedin_badge

facebook_badge

Login




  • Forgot your password?
  • Forgot your username?
  • Create an account

Who's Online

We have 164 guests online

Latest Events

No events
copyright © World Health Advocacy Inc.